entity

cystatin C

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about cystatin C: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

8Connections
1Hypotheses
1Analyses
5Outgoing
3Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (5)

TargetRelationTypeStr
TREM2activatesprotein0.70
neuroinflammationpreventsmechanism0.70
complement cascademodulatespathway0.70
amyloid plaquesreducesphenotype0.70
CSF inflammatory markersassociated_withbiomarker0.70

Incoming (3)

SourceRelationTypeStr
LRP1regulatesprotein0.70
cancercausesphenotype0.70
systemic cancercausesphenotype0.70

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Direct cystatin C inhibition of tau aggregation 0.390 neurodegeneration Does the cancer-cystatin-C-TREM2 pathway

Mentioning Analyses (1)

Scientific analyses that reference this entity

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

neurodegeneration | 2026-04-25 | 8 hypotheses Top: 0.640

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

closed · Rounds: 4 · Score: 0.66 · 2026-04-25

Related Research

Hypotheses and analyses mentioning cystatin C in their description or question text

No additional research found